Vito Palombella, our Chief Scientific Officer, writes about the role in cancer growth played by the adenosine axis, and how immunotherapy candidates like Surface’s SRF617 hold promise for restoring anti-tumor immunity: https://t.co/MqCgymAtsn
Vito Palombella, our Chief Scientific Officer, writes about the role in cancer growth played by the adenosine axis, and how immunotherapy candidates like Surface’s SRF617 hold promise for restoring anti-tumor immunity: https://t.co/MqCgymAtsn